(Q58235847)

English

Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

0 references

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1

object named as

Man-Fung Yuen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

John Chi-Hang Yuen

5

object named as

John Chi-Hang Yuen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Danny Ka-Ho Wong

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

0 references

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

106

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1264-1271

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Chronic hepatitis B--new goals, new treatment.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.45

21 January 2018

Identifiers

10.1038/AJG.2011.45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21364549%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58235847&oldid=1753034210"